Enlivex Therapeutics (ENLV) announced that it has initiated a process to voluntarily delist its ordinary shares, par value NIS 0.40 per share, from the Tel Aviv Stock Exchange.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENLV:
- Enlivex Therapeutics price target raised to $13 from $7 at H.C. Wainwright
- Enlivex Lists RAIN Treasury Token on KuCoin to Deepen Liquidity and Market Access
- Enlivex says RAIN token listed on KuCoin crypto exchange
- Enlivex Therapeutics files to sell 212M ordinary shares for holders
- Enlivex Calls February 2026 Extraordinary Meeting to Approve Governance Changes and Reverse Share Split